The American Society of Health-System Pharmacists (ASHP) announced Sept. 21 the introduction of its Center on Pharmacy Practice Model Advancement to aid ASHP’s Pharmacy Practice Model Initiative (PPMI).
The American Society of Health-System Pharmacists (ASHP) announced Sept. 21 the introduction of its Center on Pharmacy Practice Model Advancement to aid ASHP's Pharmacy Practice Model Initiative (PPMI).
The goal of the PPMI is to develop a practice model in which pharmacists are used more effectively as direct patient care providers, according to PPMI's website."The establishment of this Center demonstrates ASHP's strong commitment to enhancing our practice model so that all patients in hospitals and clinics who require the direct patient care services of a pharmacist receive them," said ASHP CEO Paul W. Abramowitz, PharmD, FASHP, in the release.
The center will launch in late October, and it will be led by Steven P. Nelson, BS Pharm, MS.
Nelson most recently served as the interim director of the Department of Pharmaceutical Care at the University of Iowa Hospitals and Clinics, where he spent more than 25 years.
"Steve's extensive leadership and management skills will be a tremendous asset as we make this vision of care a reality," Abramowitz said in the release.Nelson will oversee PPMI activities and analyze the feasibility and effectiveness of potential programs and projects for pharmacy practice models in hospitals, health systems, and ambulatory clinics.
-----------------------------------------------------------
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
Stress Ulcer Prophylaxis May Not Prevent Gastrointestinal Bleeding in Neonates
December 4th 2023According to a poster presented at ASHP Midyear 2023, stress ulcer prophylaxis (SUP) did not increase adverse effects, suggesting limited preventive benefits for gastrointestinal bleeding (GIB) in neonates.
Instagram Could Serve as Educational Platform for New FDA Drug Approvals
December 4th 2023An evaluative study on an open resource Instagram page that provides information on new medications to pharmacists was recently presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition.